Trial · NCT01598090
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period | STARTED | Part A: Peginterferon Lambda-1a + RBV + TVR (Open Label) | 27 | |
| Treatment Period | STARTED | Part B: Peginterferon Lambda-1a + RBV + TVR | 411 | |
| Treatment Period | STARTED | Part B: Peginterferon Alfa-2a + RBV + TVR | 206 | |
| Treatment Period | COMPLETED | Part A: Peginterferon Lambda-1a + RBV + TVR (Open Label) | 16 | |
| Treatment Period | COMPLETED | Part B: Peginterferon Lambda-1a + RBV + TVR | 339 | |
| Treatment Period | COMPLETED | Part B: Peginterferon Alfa-2a + RBV + TVR | 171 | |
| Treatment Period | NOT COMPLETED | Part A: Peginterferon Lambda-1a + RBV + TVR (Open Label) | 11 | |
| Treatment Period | NOT COMPLETED | Part B: Peginterferon Lambda-1a + RBV + TVR | 72 | |
| Treatment Period | NOT COMPLETED | Part B: Peginterferon Alfa-2a + RBV + TVR | 35 | |
| Follow-up Period | STARTED | Part A: Peginterferon Lambda-1a + RBV + TVR (Open Label) | 26 | |
| Follow-up Period | STARTED | Part B: Peginterferon Lambda-1a + RBV + TVR | 399 | |
| Follow-up Period | STARTED | Part B: Peginterferon Alfa-2a + RBV + TVR | 199 | |
| Follow-up Period | COMPLETED | Part A: Peginterferon Lambda-1a + RBV + TVR (Open Label) | 21 | |
| Follow-up Period | COMPLETED | Part B: Peginterferon Lambda-1a + RBV + TVR | 364 | |
| Follow-up Period | COMPLETED | Part B: Peginterferon Alfa-2a + RBV + TVR | 171 | |
| Follow-up Period | NOT COMPLETED | Part A: Peginterferon Lambda-1a + RBV + TVR (Open Label) | 5 | |
| Follow-up Period | NOT COMPLETED | Part B: Peginterferon Lambda-1a + RBV + TVR | 35 | |
| Follow-up Period | NOT COMPLETED | Part B: Peginterferon Alfa-2a + RBV + TVR | 28 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01598090/flow